Xiaoning Wang

机构：Shandong University, China Pharmaceutical University, Ruijin Hospital, Gannan Medical University, First Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Gannan Medical University, Gilead Sciences (United States), Communication University of China, Southeast University · ORCID：0000-0002-7925-2774

发表论文 317 篇 · 总被引 4825 次 · h-index 32

代表论文

• Emerging Artificial Intelligence Technologies for Risk Assessment and Management in Acute Myeloid Leukemia (2025 · JAMA Oncology · 被引 6)
• Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial (2025 · American Journal of Hematology · 被引 6)
• Exploring the Active Substances and Mechanism of Physalis Calyx seu Fructus Against Inflammation‐related Respiratory Diseases via Integrating Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry, Network Pharmacological Analysis, and Experimental Verification (2025 · Chemistry & Biodiversity · 被引 3)
• Harnessing the power of exosomes in leukemia: from molecular messengers to clinical applications (2025 · Discover Oncology · 被引 3)
• Tandem‐Activatable PROTAC Prodrug for Tumor Biomarker‐Driven Near‐Infrared Opto‐Proteolysis (2025 · Angewandte Chemie · 被引 3)
• Integrated Two-Analyte Population Pharmacokinetics Model of Patritumab Deruxtecan (HER3-DXd) Monotherapy in Patients with Solid Tumors (2025 · Clinical Pharmacokinetics · 被引 3)